<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Reported-in-Senate" public-private="public">
	<form>
		<distribution-code display="yes">II</distribution-code>
		<calendar>Calendar No. 549</calendar>
		<congress>110th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>S. 1551</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20070605">June 5, 2007</action-date>
			<action-desc><sponsor name-id="S307">Mr. Brown</sponsor> (for himself,
			 <cosponsor name-id="S235">Mrs. Hutchison</cosponsor>, <cosponsor name-id="S055">Mr. Kennedy</cosponsor>, <cosponsor name-id="S278">Mrs.
			 Clinton</cosponsor>, <cosponsor name-id="S229">Mrs. Murray</cosponsor>,
			 <cosponsor name-id="S221">Mrs. Feinstein</cosponsor>, <cosponsor name-id="S313">Mr. Sanders</cosponsor>, <cosponsor name-id="S167">Mr.
			 Bingaman</cosponsor>, <cosponsor name-id="S306">Mr. Menendez</cosponsor>,
			 <cosponsor name-id="S172">Mr. Harkin</cosponsor>, <cosponsor name-id="S223">Mrs. Boxer</cosponsor>, <cosponsor name-id="S258">Ms.
			 Landrieu</cosponsor>, <cosponsor name-id="S275">Ms. Cantwell</cosponsor>,
			 <cosponsor name-id="S288">Ms. Murkowski</cosponsor>, and
			 <cosponsor name-id="S166">Mr. Lautenberg</cosponsor>) introduced the following
			 bill; which was read twice and referred to the
			 <committee-name added-display-style="italic" committee-id="SSHR00" deleted-display-style="strikethrough">Committee on Health, Education, Labor,
			 and Pensions</committee-name></action-desc>
		</action>
		<action stage="Reported-in-Senate">
			<action-date>December 18, 2007</action-date>
			<action-desc>Reported by <sponsor name-id="S055">Mr. Kennedy</sponsor>,
			 with an amendment</action-desc>
			<action-instruction>Strike out all after the enacting clause and insert
			 the part printed in italic</action-instruction>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To amend the Public Health Service Act with respect to
		  making progress toward the goal of eliminating tuberculosis, and for other
		  purposes.</official-title>
	</form>
	<legis-body>
		<section changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HA6F492E816B54087A5B5960551EEE77" reported-display-style="strikethrough" section-type="section-one"><enum>1.</enum><header>Short title; table of
			 contents</header>
			<subsection id="H2DE3EAC47F924FAA8E3EE6537B72A57F"><enum>(a)</enum><header>Short
			 title</header><text display-inline="yes-display-inline">This Act may be cited
			 as the <quote><short-title>Comprehensive Tuberculosis
			 Elimination Act of 2007</short-title></quote>.</text>
			</subsection><subsection id="H32ABF15A1D6941838726C21FD584096E"><enum>(b)</enum><header>Table of
			 contents</header><text display-inline="yes-display-inline">The table of
			 contents for this Act is as follows:</text>
				<toc changed="deleted" committee-id="SSHR00" container-level="legis-body-container" lowest-bolded-level="division-lowest-bolded" lowest-level="section" quoted-block="no-quoted-block" regeneration="yes-regeneration" reported-display-style="strikethrough">
					<toc-entry idref="HA6F492E816B54087A5B5960551EEE77" level="section">Sec. 1. Short title;
				table of contents.</toc-entry>
					<toc-entry idref="HD12DEE93845846BEA28E70E79B5CBAAB" level="section">Sec. 2. Findings.</toc-entry>
					<toc-entry idref="H587893FDC81A422FAFD16FDD5BED854E" level="title">Title I—Centers for Disease Control and
				Prevention</toc-entry>
					<toc-entry idref="HAAD1F03A12D044DFA9DF9ECEB3D14DFC" level="subtitle">Subtitle A—National program for
				elimination of tuberculosis</toc-entry>
					<toc-entry idref="H22FA78E8BB6A4639854052F13949F8EE" level="section">Sec. 101. National program.</toc-entry>
					<toc-entry idref="H0266F1D89689432481228C71179D004B" level="subtitle">Subtitle B—Interagency
				collaboration</toc-entry>
					<toc-entry idref="HC7F6865EC76C447DA900D96E65065700" level="section">Sec. 111. Advisory council for
				elimination of tuberculosis.</toc-entry>
					<toc-entry idref="H855320789197443681E3A972C4D626E2" level="subtitle">Subtitle C—New tools for tuberculosis
				elimination</toc-entry>
					<toc-entry idref="H3485E3CB46A842B098EF3CEAC1CD788" level="section">Sec. 121. New
				tools.</toc-entry>
					<toc-entry idref="H20A2471BF09344B6B35193CECC1FE620" level="subtitle">Subtitle D—Authorizations of
				appropriations</toc-entry>
					<toc-entry idref="HDA4BDE586B724F75B70059A41006B74" level="section">Sec. 131. Authorizations
				of appropriations.</toc-entry>
					<toc-entry idref="H211267994AD84E4388851C2F63ECD1F9" level="title">Title II—National Institutes of
				Health</toc-entry>
					<toc-entry idref="HF2BC1F9B5F434D39B61BEC61BC7E8E" level="section">Sec. 201. Research and development
				concerning tuberculosis.</toc-entry>
					<toc-entry idref="H0C00B4FE21C640E392F20027F309F441" level="section">Sec. 202. Activities of National
				institute of Allergy and Infectious Diseases.</toc-entry>
					<toc-entry idref="HC9D5481D0B244A82AD40E9F1C6DE74FD" level="section">Sec. 203. John E. Fogarty International
				Center for Advanced Study in the Health Sciences.</toc-entry>
					<toc-entry idref="H0B1048D532E04E9100C0D54C99B995CD" level="section">Sec. 204. Loan repayment programs
				regarding research on tuberculosis.</toc-entry>
					<toc-entry idref="H7B872A6E09D34E6F91EAD0CE125BB0AB" level="section">Sec. 205. Authorization of
				appropriations.</toc-entry>
				</toc>
			</subsection></section><section changed="deleted" committee-id="SSHR00" id="HD12DEE93845846BEA28E70E79B5CBAAB" reported-display-style="strikethrough"><enum>2.</enum><header>Findings</header><text display-inline="no-display-inline">The Congress finds as follows:</text>
			<paragraph id="H41B95587FCFE42FB9B91FC588CE64686"><enum>(1)</enum><text display-inline="yes-display-inline">Each year approximately 9,000,000 people
			 become ill with active tuberculosis ( referred to in this section as
			 <quote>TB</quote>), and it is estimated that 1,600,000 of those people die, a
			 result of critical underinvestment in quality TB control and the research and
			 development of new TB drugs, diagnostics and a vaccine, as well as the comorbid
			 relationship between TB and HIV/AIDS. Such levels of morbidity and mortality
			 are complicated by the disease having the ability to develop resistance to
			 treatments and to travel easily across borders.</text>
			</paragraph><paragraph id="H67C19E40E41E472BBCFCF55F66A76491"><enum>(2)</enum><text>In 2006, there
			 were 13,767 cases of active TB reported in the United States. The average
			 annual decline in the national TB rate slowed from 7.3 percent per year in the
			 period of 1993 to 2000 to 3.8 percent per year in the period of 2000 to
			 2006.</text>
			</paragraph><paragraph id="HF225B6BB7EF44A0192E3C7AC2FB8BCB4"><enum>(3)</enum><text>In addition to
			 those with active TB, an estimated 10,000,000 to 15,000,000 people in the
			 United States have latent TB infection.</text>
			</paragraph><paragraph id="H9AC3545B92EC49C4909CA8E3C79E38BF"><enum>(4)</enum><text>The increasing
			 occurrence of multidrug resistant (<quote>MDR</quote>) TB, including
			 extensively drug resistant (<quote>XDR</quote>) TB—which is resistant to at
			 least almost all drugs used to treat TB, including the two recommended
			 first-line drugs and the recommended second-line medications, raises concerns
			 of a future epidemic of virtually untreatable TB.</text>
			</paragraph><paragraph id="id4C7946F71C264E3590530BFCB4024D15"><enum>(5)</enum><text>To prevent the
			 spread of extensively drug resistant TB, the immediate strengthening of TB
			 control systems must be a priority. This includes improved case detection,
			 strengthened laboratory capacity, rapid implementation of infection control
			 measures, enhanced treatment programs, and immediate support to existing public
			 sector infrastructure.</text>
			</paragraph><paragraph id="HBF476A31D18A4D3900B7AC008C785C94"><enum>(6)</enum><text display-inline="yes-display-inline">The Centers for Disease Control and
			 Prevention is increasingly relied upon globally for its expertise and technical
			 assistance in global tuberculosis preparedness and outbreak response capacity
			 to identify and investigate outbreaks of multidrug resistant and extensively
			 drug resistant TB.</text>
			</paragraph><paragraph id="H08D1E995111F4CCE85EE28E52ECF01DE"><enum>(7)</enum><text>New tools are
			 needed to more effectively prevent, diagnose, and treat TB. The standard method
			 of diagnosing TB is over 100 years old, and fails to adequately detect TB,
			 especially in children and those co-infected with HIV/AIDS. The newest class of
			 anti-TB drug is over 40 years old, while rates of multidrug resistant TB are
			 rising globally. The existing vaccine confers no protection to adolescents and
			 adults, protecting only against severe forms of TB in infants and young
			 children.</text>
			</paragraph></section><title changed="deleted" committee-id="SSHR00" id="H587893FDC81A422FAFD16FDD5BED854E" reported-display-style="strikethrough"><enum>I</enum><header>Centers for
			 Disease Control and Prevention</header>
			<subtitle id="HAAD1F03A12D044DFA9DF9ECEB3D14DFC"><enum>A</enum><header>National program
			 for elimination of tuberculosis</header>
				<section id="H22FA78E8BB6A4639854052F13949F8EE"><enum>101.</enum><header>National
			 program</header><text display-inline="no-display-inline">Section 317E of the
			 Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/247b-6">42 U.S.C. 247b–6</external-xref>) is
			 amended—</text>
					<paragraph id="H23D535A6AD964297A709DDFED7388F1E"><enum>(1)</enum><text display-inline="yes-display-inline">by striking the heading for the section and
			 inserting the following: <quote><header-in-text level="section" style="traditional">national program for elimination of
			 tuberculosis</header-in-text></quote>; and</text>
					</paragraph><paragraph id="HE02032D80251476A9847319998CAE968"><enum>(2)</enum><text>by amending
			 subsection (b) to read as follows:</text>
						<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HC88AC19EC2174D948578B3DAE7ABC419" reported-display-style="strikethrough" style="OLC">
							<subsection id="H786B79D76FD6489186DAE662869F1784"><enum>(b)</enum><header>Research and
				development; demonstration projects; education and training</header><text display-inline="yes-display-inline">With respect to the prevention, treatment,
				control, and elimination of tuberculosis, the Secretary may, directly or
				through grants to public or nonprofit private entities, carry out the
				following:</text>
								<paragraph id="HB09B96FF7FB44D70A9A22EBC6655677B"><enum>(1)</enum><text display-inline="yes-display-inline">Research, with priority given to research
				and development concerning—</text>
									<subparagraph id="H25BE22C1AC1E4D93972B56FEAEE5D474"><enum>(A)</enum><text>clinical trials to
				evaluate the safety and effectiveness of new drugs, diagnostics, and vaccines
				for latent tuberculosis infection and active tuberculosis, including
				drug-resistant tuberculosis, that are suitable for use by patients with
				HIV/AIDS;</text>
									</subparagraph><subparagraph id="H54051D48914E4832BDA148493967E468"><enum>(B)</enum><text>epidemiological
				studies of populations at risk for tuberculosis; and</text>
									</subparagraph><subparagraph id="H1225F168206B4A3C917E73DD277D059E"><enum>(C)</enum><text display-inline="yes-display-inline">field studies to evaluate the effectiveness
				of new drugs, diagnostics, and vaccines, to assess the incidence and prevalence
				of multidrug resistant and extensively drug resistant strains of
				tuberculosis.</text>
									</subparagraph></paragraph><paragraph id="HA3C93F7FF44540B200D5F193E03BFAF"><enum>(2)</enum><text>Demonstration
				projects for—</text>
									<subparagraph id="HC2CBD812F9D040FA8E14FE69114EA6B"><enum>(A)</enum><text>the development of
				regional capabilities to prevent, control and eliminate tuberculosis and
				prevent mutidrug resistant and extensively drug resistant strains of
				tuberculosis;</text>
									</subparagraph><subparagraph id="HA614CD8F452741198FE8875E2233E5D5"><enum>(B)</enum><text display-inline="yes-display-inline">the intensification of efforts—</text>
										<clause id="HC5194A86232746B681DB6199D906A818"><enum>(i)</enum><text>to prevent,
				detect, and treat tuberculosis among African Americans, Hispanic Americans,
				Asian Americans, and other United States-born populations with documented
				health disparities; and</text>
										</clause><clause id="H25BA0F068D364B2D92DDA3ACA5E06700"><enum>(ii)</enum><text>to reduce or
				eliminate racial disparities in the incidence of tuberculosis in these
				populations;</text>
										</clause></subparagraph><subparagraph id="H8E56B60EB4E84027B4355877A5F7CF92"><enum>(C)</enum><text display-inline="yes-display-inline">the intensification of efforts to control
				tuberculosis along the United States-Mexico border and among United
				States-Mexico binational populations;</text>
									</subparagraph><subparagraph id="H8A5F317A9F134203978BFEFC5BB1E619"><enum>(D)</enum><text>the
				intensification of efforts to prevent, detect, and treat tuberculosis among
				foreign-born persons who are in the United States;</text>
									</subparagraph><subparagraph id="IDe44cf8220ec64bd6a373989799b07dd3"><enum>(E)</enum><text>providing guidance
				to Immigration and Customs Enforcement in developing risk-based screening
				procedures based on current epidemiological data;</text>
									</subparagraph><subparagraph id="ID225effc8abfb4daf9ebfc761f341164f"><enum>(F)</enum><text>the
				intensification of efforts to increase targeted testing and treatment of latent
				tuberculosis infection and drug-resistant tuberculosis; and</text>
									</subparagraph><subparagraph id="ID405722446c5b4d60bcbe0999fad07a9a"><enum>(G)</enum><text>the
				intensification of efforts to prevent, detect, and treat tuberculosis among
				other high risk populations and settings, including among children and
				adolescents, homeless persons, detainees and prisoners, HIV-infected persons,
				and within health care settings.</text>
									</subparagraph></paragraph><paragraph id="HC1FB71F339784B0380C3CC72CA639C2C"><enum>(3)</enum><text>A public
				information and education program to include components that raise awareness
				regarding tuberculosis among the general population as well as those that
				target populations documented as having high risk for tuberculosis.</text>
								</paragraph><paragraph id="HDD4A6A80B6BB4D349D6D82413916C8A1"><enum>(4)</enum><text>Education,
				training and clinical skills improvement activities for health professionals,
				including allied health personnel and emergency response employees.</text>
								</paragraph><paragraph id="H93BB588B28FD4394AE84D13BE4A34D31"><enum>(5)</enum><text display-inline="yes-display-inline">Provide support for the Tuberculosis Trials
				Consortium, the Tuberculosis Epidemiologic Studies Consortium, the National
				Laboratory Training Network, and Regional Training and Medical Consultation
				Centers to carry out activities under paragraphs (1) through (4).</text>
								</paragraph><paragraph id="HBCF7D762D99040199094B355A4001E5F"><enum>(6)</enum><text display-inline="yes-display-inline">Collaboration with international
				organizations and foreign countries in intensifying efforts to prevent, treat,
				control, and eliminate tuberculosis, including efforts that address risks
				associated with international travel.</text>
								</paragraph><paragraph id="ID8bfc3d782bc9466484abe983ae6ebeca"><enum>(7)</enum><text>Develop, enhance,
				and expand information technologies that support tuberculosis control,
				including surveillance and database management systems with
				cross-jurisdictional
				capabilities.</text>
								</paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
					</paragraph></section></subtitle><subtitle id="H0266F1D89689432481228C71179D004B"><enum>B</enum><header>Interagency
			 collaboration</header>
				<section id="HC7F6865EC76C447DA900D96E65065700"><enum>111.</enum><header>Advisory
			 council for elimination of tuberculosis</header>
					<subsection id="H9D38BC19C11541FB9EDFD90294E39C"><enum>(a)</enum><header>In
			 general</header><text display-inline="yes-display-inline">Section 317E(f) of
			 the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/247b-6">42 U.S.C. 247b–6(f)</external-xref>) is
			 amended—</text>
						<paragraph id="HF41465F9D5E440E58E1F57EB1068F607"><enum>(1)</enum><text display-inline="yes-display-inline">by redesignating paragraph (5) as paragraph
			 (6); and</text>
						</paragraph><paragraph id="HEEA6870E6F2A4F328E585C3569B84799"><enum>(2)</enum><text>by striking
			 paragraphs (2) through (4), and inserting the following:</text>
							<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HF9DAB14ED34E4FE1BED784E6E3DB001C" reported-display-style="strikethrough" style="OLC">
								<paragraph id="HB5F36E9952144D07BCD7F5DAF503EC00"><enum>(2)</enum><header>Duties</header><text display-inline="yes-display-inline">The Council shall provide advice and
				recommendations regarding the elimination of tuberculosis to the Secretary, the
				Assistant Secretary for Health, and the Director of the Centers for Disease
				Control and Prevention. In addition, the Council shall, with respect to
				eliminating such disease, provide to the Secretary and other appropriate
				Federal officials advice on—</text>
									<subparagraph id="HCF6339CB477D4F749BDC219700A02FD"><enum>(A)</enum><text>coordinating the
				activities of the Public Health Service and other Federal agencies that relate
				to the disease, including activities under subsection (b);</text>
									</subparagraph><subparagraph id="ID273b47b646d846fb952f29979e8ce074"><enum>(B)</enum><text>responding rapidly
				and effectively to cases of extensively drug resistant strains of tuberculosis;
				and</text>
									</subparagraph><subparagraph id="HCE781C38199E4D71AFF993647EF5B9B"><enum>(C)</enum><text>efficiently
				utilizing the Federal resources involved.</text>
									</subparagraph></paragraph><paragraph id="HC41E1E0E5DD24EF8A56064A697CECCA"><enum>(3)</enum><header>Comprehensive
				plan</header>
									<subparagraph id="H1D118840450949019FADBC3640DA1C74"><enum>(A)</enum><header>In
				general</header><text>In carrying out paragraph (2), the Council shall make
				recommendations on the development, revision, and implementation of a
				comprehensive plan to eliminate tuberculosis in the United States.</text>
									</subparagraph><subparagraph id="H52BFFE6A97A64A0E9506688D04A743F8"><enum>(B)</enum><header>Consultation</header><text>In
				carrying out subparagraph (A), the Council shall consult with public and
				private entities, including—</text>
										<clause id="HA9943EC3C3314845B01293205C2C86CF"><enum>(i)</enum><text>individuals who
				are scientists, physicians, laboratorians, and other health professionals, who
				are not officers or employees of the Federal Government and who represent the
				disciplines relevant to tuberculosis elimination;</text>
										</clause><clause commented="no" id="H5B768872B16B4B37B40129558F00EB5"><enum>(ii)</enum><text>members of
				public-private partnerships established to address the elimination of
				tuberculosis;</text>
										</clause><clause id="HBF22159D321F44AD8390ABF6C9A9894F"><enum>(iii)</enum><text>members of
				national and international nongovernmental organizations established to address
				tuberculosis elimination; and</text>
										</clause><clause id="H5EDFA585B62D4999B98EEFAD7CA489FE"><enum>(iv)</enum><text>members from the
				general public who are knowledgeable with respect to tuberculosis elimination
				including individuals who have or have had tuberculosis.</text>
										</clause></subparagraph><subparagraph commented="no" id="HC24E745883924C26A304A417D56CCD73"><enum>(C)</enum><header>Certain
				components of plan</header><text display-inline="yes-display-inline">In
				carrying out subparagraph (A), the Council shall—</text>
										<clause commented="no" id="H1873697423FA4FFBB2DB907843058B78"><enum>(i)</enum><text>consider the
				recommendations of the Institute of Medicine regarding the elimination of
				tuberculosis;</text>
										</clause><clause commented="no" id="H42099F892868412396A8282CCCABF1E2"><enum>(ii)</enum><text>consider
				recommendations for the involvement of the United States in continuing global
				and cross-border tuberculosis control activities in countries where a high
				incidence of tuberculosis directly affects the United States such as Mexico;
				and</text>
										</clause><clause commented="no" id="H24DAC00AF9FD47679DD5C6CB5D5CDCB"><enum>(iii)</enum><text>review the
				extent to which progress has been made toward eliminating tuberculosis.</text>
										</clause></subparagraph></paragraph><paragraph commented="no" id="H878B11381C304C0A921408BF80DB3B96"><enum>(4)</enum><header>Annual
				report</header><text>The Council shall annually submit to Congress and the
				Secretary a report on the activities carried under this section, other than
				subsection (g). Each such report shall include the opinion of the Council on
				the extent to which its recommendations regarding the elimination of
				tuberculosis have been implemented, including with respect to—</text>
									<subparagraph commented="no" id="H8D4963E8A43B401585F08C5E2CB4097F"><enum>(A)</enum><text>activities under
				subsection (b); and</text>
									</subparagraph><subparagraph commented="no" id="HD84D44A50D824C3F9CC67367E009E67B"><enum>(B)</enum><text>the national plan
				referred to in paragraph (3).</text>
									</subparagraph></paragraph><paragraph id="HC091791F7C2C44E4A8FCD2F43E3636F8"><enum>(5)</enum><header>Composition</header><text>The
				Council shall be composed of—</text>
									<subparagraph id="H6614962D492B4224A0213370CA138F6D"><enum>(A)</enum><text>representatives
				from the Centers for Disease Control and Prevention, the National Institutes of
				Health, the United States Agency for International Development, the Agency for
				Healthcare Research and Quality, the Health Resources and Services
				Administration, the United States-Mexico Border Health Commission, and other
				Federal departments and agencies that carry out significant activities related
				to tuberculosis;</text>
									</subparagraph><subparagraph id="H5C2AF207847A458B81A251C3DB71E398"><enum>(B)</enum><text>State and local
				tuberculosis control and public health officials;</text>
									</subparagraph><subparagraph id="H800A9B23B28840E4A19B857D46C71486"><enum>(C)</enum><text display-inline="yes-display-inline">individuals who are scientists, physicians,
				laboratorians, and other health professionals who represent disciplines
				relevant to tuberculosis elimination;</text>
									</subparagraph><subparagraph id="H7C695176C7DE4CAEB553732855764909"><enum>(D)</enum><text>members of
				national and international nongovernmental organizations established to address
				the elimination of tuberculosis; and</text>
									</subparagraph><subparagraph id="HB7FCA9D1C0D94156964B958E35712C1F"><enum>(E)</enum><text>members from the
				general public who are knowledgeable with respect to the elimination of
				tuberculosis, including individuals who have or have had
				tuberculosis.</text>
									</subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
						</paragraph></subsection><subsection id="H8722352FD20943479C6EE33369B18B23"><enum>(b)</enum><header>Rule of
			 construction regarding current membership</header><text>With respect to the
			 advisory council under section 317E(f) of the Public Health Service Act, the
			 amendments made by subsection (a) may not be construed as terminating the
			 membership on such council of any individual serving as such a member as of the
			 day before the date of the enactment of this Act.</text>
					</subsection></section></subtitle><subtitle id="H855320789197443681E3A972C4D626E2"><enum>C</enum><header>New tools for
			 tuberculosis elimination</header>
				<section id="H3485E3CB46A842B098EF3CEAC1CD788"><enum>121.</enum><header>New
			 tools</header><text display-inline="no-display-inline">Section 317E of the
			 Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/247b-6">42 U.S.C. 247b–6</external-xref>) is
			 amended—</text>
					<paragraph id="HBF7F762E800A440EB8D9C667AAE91DC"><enum>(1)</enum><text>by redesignating
			 subsection (g) as subsection (h); and</text>
					</paragraph><paragraph id="H3281035885A44243A38E50781673F47D"><enum>(2)</enum><text>by inserting after
			 subsection (f) the following subsection:</text>
						<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="HC06B9B750DEF479FB128578800A1006B" reported-display-style="strikethrough" style="OLC">
							<subsection id="H655A9DE7F2374EEEAFAAD638E72CB01"><enum>(g)</enum><header>New tools for
				elimination of tuberculosis</header>
								<paragraph id="H936738584DC4458E8275B8E4001DAD46"><enum>(1)</enum><header>Research and
				development on drugs, diagnostics, vaccines, and public health
				interventions</header><text>The Secretary, acting through the Director of the
				Centers for Disease Control and Prevention, shall expand, intensify, and
				coordinate research and development and related activities of such Centers to
				develop new tools for the elimination of tuberculosis, including drugs,
				diagnostics, vaccines, and public health interventions, such as directly
				observed therapy and non-pharmaceutical intervention.</text>
								</paragraph><paragraph id="H8408E30BCB0B4FF99F58F93BE971EE3"><enum>(2)</enum><header>Federal
				tuberculosis task force</header>
									<subparagraph id="HA28C20AC3B374290BC97E400892CF001"><enum>(A)</enum><header>Duties</header><text>The
				Federal Tuberculosis Task Force (established in December 2001 as part of the
				Centers for Disease Control and Prevention) (in this subsection referred to as
				the <quote>Task Force</quote>) shall provide to the Secretary and other
				appropriate Federal officials advice on the implementation of paragraph (1),
				including advice regarding the efficient utilization of the Federal resources
				involved.</text>
									</subparagraph><subparagraph id="H5580C2C12FAE4776AD04C9D4838FEBB3"><enum>(B)</enum><header>Comprehensive
				plan for new tools development</header><text>In carrying out paragraph (1), the
				Task Force shall make recommendations on the development of a comprehensive
				plan for the creation of new tools for the elimination of tuberculosis,
				including drugs, diagnostics, and vaccines.</text>
									</subparagraph><subparagraph id="HA7E49ACB6B014836B0898C3317E56970"><enum>(C)</enum><header>Consultation</header><text>In
				developing the comprehensive plan under paragraph (1), the Task Force shall
				consult with—</text>
										<clause id="H259E762A49AC47958E9DE0D963DC3AB"><enum>(i)</enum><text>scientists,
				physicians, laboratorians, and other health professionals and who represent the
				specialties and disciplines relevant to the research under
				consideration;</text>
										</clause><clause id="H363DED60A0A344B6A0273DFB28996EB7"><enum>(ii)</enum><text display-inline="yes-display-inline">members from public-private partnerships or
				foundations (or both) engaged in research relevant to research under
				consideration;</text>
										</clause><clause id="HDCBF504FF10C4FDBAFAEA00557C6ADE8"><enum>(iii)</enum><text>members of
				national and international nongovernmental organizations established to address
				tuberculosis elimination;</text>
										</clause><clause id="HE97DC39269424CEC8F6BC6DAD6BB73B8"><enum>(iv)</enum><text>members from the
				general public who are knowledgeable with respect to tuberculosis, including
				individuals who have or have had tuberculosis; and</text>
										</clause><clause id="HF37451D3E82B419FB710AB64C9EA101"><enum>(v)</enum><text>scientists,
				physicians, laboratorians, and other health professionals who reside in a
				foreign country with a substantial incidence or prevalence of tuberculosis, and
				who represent the specialties and disciplines relevant to the research under
				consideration.</text>
										</clause></subparagraph></paragraph><paragraph id="H72EC28D2EA244D1198CD881628FA8852"><enum>(3)</enum><header>Grants and
				contracts</header><text>The Secretary shall carry out paragraph (1) directly
				and through awards of grants, cooperative agreements, and contracts to public
				and private entities, including—</text>
									<subparagraph id="HD5F283C20B2D44648D9B43A52EE850E0"><enum>(A)</enum><text>public-private
				partnerships;</text>
									</subparagraph><subparagraph id="HEBDF78CA071C4B7E964E5200DE48B983"><enum>(B)</enum><text>academic
				institutions, including institutions of higher education;</text>
									</subparagraph><subparagraph id="H5E45ECBA17F443488053E95760D834E0"><enum>(C)</enum><text>research
				institutions; and</text>
									</subparagraph><subparagraph id="HA3672B7A569E40F18300DB7CF2B51F98"><enum>(D)</enum><text display-inline="yes-display-inline">the Tuberculosis Trials Consortium and the
				Tuberculosis Epidemiologic Studies
				Consortium.</text>
									</subparagraph></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
					</paragraph></section></subtitle><subtitle id="H20A2471BF09344B6B35193CECC1FE620"><enum>D</enum><header>Authorizations of
			 appropriations</header>
				<section id="HDA4BDE586B724F75B70059A41006B74"><enum>131.</enum><header>Authorizations
			 of appropriations</header><text display-inline="no-display-inline">Section 317E
			 of the Public Health Service Act, as amended by section 121(1) of this Act, is
			 amended by striking subsection (h) and inserting the following:</text>
					<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="H907C94BB34BD4554BE7BD1F97BC5C625" reported-display-style="strikethrough" style="OLC">
						<subsection id="H92AC1A3890BA479293A408F6E6B0B51C"><enum>(h)</enum><header>Authorization of
				appropriations</header>
							<paragraph id="H9DB0BFACBC2C41D98E9E78C447BEAF2F"><enum>(1)</enum><header>General
				program</header>
								<subparagraph id="H7AF52EA720774E91A0B763CB928D5BA0"><enum>(A)</enum><header>In
				general</header><text>For the purpose of carrying out this section, other than
				subsections (b) and (g), there are authorized to be appropriated $300,000,000
				for fiscal year 2008, and such sums as may be necessary for each of the fiscal
				years 2009 through 2012.</text>
								</subparagraph><subparagraph id="H2FDA6F125689406CB717FAC45FE97D79"><enum>(B)</enum><header>Reservation for
				emergency grants</header><text>Of the amounts appropriated under subparagraph
				(A) for a fiscal year, the Secretary may reserve not more than 25 percent for
				emergency grants under subsection (a) for any State, political subdivision of a
				States, or other public entity in which there is, relative to other areas, a
				substantial number of cases of tuberculosis, multidrug resistant tuberculosis,
				or extensively drug resistant tuberculosis or a substantial rate of increase in
				such cases.</text>
								</subparagraph><subparagraph id="id6F18CECA2D7A49E48A6D3F760E329CA7"><enum>(C)</enum><header>Research,
				demonstration projects, education, and training</header><text>For the purpose
				of carrying out subsection (b), there are authorized to be appropriated such
				sums as may be necessary for each of fiscal years 2008 through 2012.</text>
								</subparagraph><subparagraph id="HA849F22132CA40BB8970C632FBEA8EE9"><enum>(D)</enum><header>Priority</header><text display-inline="yes-display-inline">In allocating amounts appropriated under
				subparagraph (A) and not reserved under subparagraph (B), the Secretary shall
				give priority to allocating such amounts for grants under subsection
				(a).</text>
								</subparagraph><subparagraph id="HEDA3A1FB868C4F65938C1265C5AD2D77"><enum>(E)</enum><header>Allocation of
				funds</header>
									<clause id="HB2CCA9B990EC416AAB100704F3000059"><enum>(i)</enum><header>Requirement of
				formula</header><text>Of the amounts appropriated under subparagraph (A), not
				reserved under subparagraph (B), and allocated by the Secretary for grants
				under subsection (a), the Secretary shall distribute such amounts to grantees
				under subsection (a) on the basis of a formula.</text>
									</clause><clause id="HFD1A6AE4E9634397BEA3CD22BED25E55"><enum>(ii)</enum><header>Relevant
				factors</header><text>The formula developed by the Secretary under clause (i)
				shall take into account the level of tuberculosis morbidity in the respective
				geographic area and may consider other factors relevant to tuberculosis in such
				area.</text>
									</clause><clause id="H8277F61F42B643D580B8E3F5F5FFEB9B"><enum>(iii)</enum><header>No change to
				formula required</header><text>This subparagraph does not require the Secretary
				to modify the formula that was used by the Secretary to distribute funds to
				grantees under subsection (a) for fiscal year 2007.</text>
									</clause></subparagraph></paragraph><paragraph id="HE5272C4B98A44ACEB74FB9002463B88C"><enum>(2)</enum><header>New
				tools</header>
								<subparagraph id="H306A74315CBA4921A5FEEE00BFF40006"><enum>(A)</enum><header>In
				general</header><text>For the purpose of carrying out subsection (g), there are
				authorized to be appropriated $100,000,000 for fiscal year 2008, and such sums
				as may be necessary for each of the fiscal years 2009 through 2012.</text>
								</subparagraph><subparagraph id="HE85053E9A33247CCB1A5C0405D944C89"><enum>(B)</enum><header>Limitation</header><text>The
				authorization of appropriations established in subparagraph (A) for a fiscal
				year is effective only if the amount appropriated under paragraph (1) for such
				year equals or exceeds the amount appropriated to carry out this section for
				fiscal year
				2007.</text>
								</subparagraph></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
				</section></subtitle></title><title changed="deleted" committee-id="SSHR00" id="H211267994AD84E4388851C2F63ECD1F9" reported-display-style="strikethrough"><enum>II</enum><header>National
			 Institutes of Health</header>
			<section id="HF2BC1F9B5F434D39B61BEC61BC7E8E"><enum>201.</enum><header>Research and
			 development concerning tuberculosis</header>
				<subsection id="idEB19211A777D4071BD8C5734CE8A618C"><enum>(a)</enum><header>In
			 general</header><text display-inline="yes-display-inline">Subpart 2 of part C
			 of title IV of the <act-name parsable-cite="PHSA">Public Health Service
			 Act</act-name> (42 U.S.C. 285b et seq.) is amended by inserting after section
			 424B the following section:</text>
					<quoted-block act-name="Public" changed="deleted" committee-id="SSHR00" id="H07956010A43946C2996573D4F3E0C38F" reported-display-style="strikethrough" style="OLC">
						<section id="H2A27BB693AC540FAA7005474CAA82121"><enum>424C.</enum><header>Tuberculosis</header>
							<subsection display-inline="no-display-inline" id="H24C6BEAFDA374844B18DFE2D52FD62AD"><enum>(a)</enum><header>In
				General</header><text>The Director of the National Institutes of Health shall
				expand, intensify, and coordinate research and development and related
				activities of the Institute with respect to tuberculosis, including activities
				toward the goal of eliminating such disease.</text>
							</subsection><subsection id="H41C5BEF8092A40B0A1018B6F180003FB"><enum>(b)</enum><header>Certain
				Activities</header><text>Activities under subsection (a) shall include—</text>
								<paragraph id="H26D58BC020684A99BF9D5BBE4617EE5C"><enum>(1)</enum><text>enhancing basic
				and clinical research on tuberculosis, including drug resistant tuberculosis;
				and</text>
								</paragraph><paragraph id="H7AF5739D5EF44623A3BC4B5E8135B7D8"><enum>(2)</enum><text>expanding research
				on the relationship between such disease and the human immunodeficiency
				virus.</text>
								</paragraph></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block>
				</subsection><subsection id="id3F5DEDB9B05F45FEAD36EA47B679C7C8"><enum>(b)</enum><header>Research
			 education</header><text>Part A of title IV of the Public Health Service Act (42
			 U.S.C. 281 et seq.) is amended by adding at the end the following:</text>
					<quoted-block changed="deleted" committee-id="SSHR00" display-inline="no-display-inline" id="idEFD04CB0C60943759FEBFF708154F57A" reported-display-style="strikethrough" style="OLC">
						<section id="id33CAAFA5017345E0B44DC3BAB45E8325"><enum>404I.</enum><header>Tuberculosis
				academic awards</header>
							<subsection id="HEF1A022DFBB04B38905CBAFF9D955B"><enum>(a)</enum><header>Tuberculosis
				academic awards</header><text>The Director of the National Institutes of Health
				may provide awards to faculty of schools of medicine, osteopathic medicine,
				nursing, public health, or related fields to assist such faculty in developing
				high quality curricula in such schools designed to significantly increase the
				opportunities for interested individuals, including students of the school and
				practicing physicians and nurses, to learn the principles and practices of
				preventing, managing, and controlling tuberculosis.</text>
							</subsection><subsection id="H5C91B92140C34F45AEC4ED8FC7CC00B0"><enum>(b)</enum><header>Tuberculosis/pulmonary
				infection awards</header><text>The Director of the National Institutes of
				Health may provide awards to support the career development of clinically
				trained professionals who are committed to research regarding pulmonary
				infections and tuberculosis by providing for supervised study and
				research.</text>
							</subsection></section><after-quoted-block>.</after-quoted-block></quoted-block>
				</subsection></section><section id="H0C00B4FE21C640E392F20027F309F441"><enum>202.</enum><header>Activities of
			 National institute of Allergy and Infectious Diseases</header><text display-inline="no-display-inline">Section 447A of the
			 <act-name parsable-cite="PHSA">Public Health Service Act</act-name> (42 U.S.C.
			 285f–2) is amended—</text>
				<paragraph id="HC47AD5FE8D024D889313E59499A5D0DD"><enum>(1)</enum><text>by striking
			 <quote>In carrying out section 446</quote> and inserting <quote>(a) In carrying
			 out section 446</quote>; and</text>
				</paragraph><paragraph id="H28B5DAB1196E4B599F38A08C9449A23E"><enum>(2)</enum><text>by inserting at
			 the end the following:</text>
					<quoted-block changed="deleted" committee-id="SSHR00" id="H53EBCD77BE844555B3A59594738F46DF" reported-display-style="strikethrough" style="OLC">
						<subsection id="H9F6CD50100DC41F2BD6CFD7E75491246"><enum>(b)</enum><text>Activities under
				subsection (a) shall include activities to develop a tuberculosis vaccine. Such
				activities shall be carried out in accordance with the blueprint for
				tuberculosis vaccine development described in the report prepared pursuant to
				the workshop convened in March 1998 by the Advisory Council for Elimination of
				Tuberculosis, the Director of the National Vaccine Program, and the Director of
				the
				Institute.</text>
						</subsection><after-quoted-block>.</after-quoted-block></quoted-block>
				</paragraph></section><section id="HC9D5481D0B244A82AD40E9F1C6DE74FD"><enum>203.</enum><header>John E. Fogarty
			 International Center for Advanced Study in the Health Sciences</header><text display-inline="no-display-inline">Section 482 of the
			 <act-name parsable-cite="PHSA">Public Health Service Act</act-name> (42 U.S.C.
			 287b) is amended—</text>
				<paragraph id="H51A2530E78F64018B715C8528BDF5236"><enum>(1)</enum><text>by inserting
			 <quote>(a) <header-in-text level="subsection" style="OLC">In
			 general</header-in-text>.—</quote> before <quote>The general
			 purpose</quote>;</text>
				</paragraph><paragraph id="H3E5C0AA430D642B391BEC21E8D9C9D5D"><enum>(2)</enum><text>in subsection (a)
			 (as so designated), by inserting after <quote>Health Sciences</quote> the
			 following: <quote>(in this subpart referred to as the
			 <quote>Center</quote>)</quote>; and</text>
				</paragraph><paragraph id="HA4B81CAAA11D4AC09C4133B816BFE368"><enum>(3)</enum><text>by adding at the
			 end the following subsection:</text>
					<quoted-block changed="deleted" committee-id="SSHR00" id="H3A65EEDB33CB40A592FFAE6CC3CCF027" reported-display-style="strikethrough" style="OLC">
						<subsection id="H6D8A9574A3304735ACD8E219529004E5"><enum>(b)</enum><header>Tuberculosis</header>
							<paragraph id="H2A84051E6CBE4B0299F73DB08820713"><enum>(1)</enum><header>In
				general</header><text>In carrying out subsection (a) with respect to
				tuberculosis, the Center shall expand, intensify, and coordinate international
				activities of the Center for research and training.</text>
							</paragraph><paragraph id="H724ED7EDE0304F6EBD98AE207FF4C29"><enum>(2)</enum><header>International
				training program</header><text>In carrying out paragraph (1), the Center shall
				carry out an international training program regarding tuberculosis. Such
				program shall be modeled after the international training program carried out
				by the Center with respect to the human immunodeficiency
				virus.</text>
							</paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
				</paragraph></section><section id="H0B1048D532E04E9100C0D54C99B995CD"><enum>204.</enum><header>Loan repayment
			 programs regarding research on tuberculosis</header><text display-inline="no-display-inline">Part G of title IV of the
			 <act-name parsable-cite="PHSA">Public Health Service Act</act-name> (42 U.S.C.
			 288 et seq.) is amended—</text>
				<paragraph id="H1E0AB14AA8A44AE88B343BF1FA88EB84"><enum>(1)</enum><text>by redesignating
			 the second section 487F as section 487G; and</text>
				</paragraph><paragraph id="HA91B9758870D4647B5BC90081E95DBC"><enum>(2)</enum><text>by inserting after
			 section 487G (as so redesignated) the following section:</text>
					<quoted-block changed="deleted" committee-id="SSHR00" id="H39DEC44BBB6F4C589328E732A68DBD8D" reported-display-style="strikethrough" style="traditional"><section id="H5386F7790D5342779C24BBA361BA49EA"><enum>487H.</enum><header>Loan repayments regarding research on
		  tuberculosis</header><text>In carrying out
				sections 487C, 487E, and 487F, the Secretary shall seek to ensure that, for
				fiscal year 2008 and subsequent fiscal years, a portion of amounts appropriated
				to carry out such sections is reserved for the purpose of entering into
				contracts under which (in accordance with the section involved) individuals
				will conduct research on tuberculosis. The Secretary shall have sole discretion
				for the administration of activities under this
				section.</text>
						</section><after-quoted-block>.</after-quoted-block></quoted-block>
				</paragraph></section><section id="H7B872A6E09D34E6F91EAD0CE125BB0AB"><enum>205.</enum><header>Authorization
			 of appropriations</header><text display-inline="no-display-inline">For the
			 purpose of carrying out this title and the amendments made by this title, there
			 are authorized to be appropriated such sums as may be necessary. Such
			 authorization of appropriations shall be in addition to the authorization of
			 appropriations established by section 402A(a) of the Public Health Service Act
			 and any other authorization of appropriations available for such
			 purpose.</text>
			</section></title></legis-body>
	<legis-body display-enacting-clause="no-display-enacting-clause">
		<section changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="ida40f0b0b-c66f-46ea-8cfa-9d2394a29aea" reported-display-style="italic" section-type="section-one"><enum>1.</enum><header>Short title; table of
			 contents</header>
			<subsection id="id07b15513-18b1-4ec5-a530-054505dbaa45"><enum>(a)</enum><header>Short
			 title</header><text display-inline="yes-display-inline">This Act may be cited
			 as the <quote><short-title>Comprehensive Tuberculosis
			 Elimination Act of 2007</short-title></quote>.</text>
			</subsection><subsection id="idc4381dca-f1e3-42c9-929d-328fb3cba5db"><enum>(b)</enum><header>Table of
			 contents</header><text display-inline="yes-display-inline">The table of
			 contents for this Act is as follows:</text>
				<toc changed="added" committee-id="SSHR00" reported-display-style="italic">
					<toc-entry idref="HA6F492E816B54087A5B5960551EEE77" level="section">Sec. 1. Short title; table of
				contents.</toc-entry>
					<toc-entry idref="H587893FDC81A422FAFD16FDD5BED854E" level="title">TITLE I—Department of health and human services
				in coordination with the centers for disease control and prevention and other
				appropriate agencies</toc-entry>
					<toc-entry idref="HAAD1F03A12D044DFA9DF9ECEB3D14DFC" level="subtitle">Subtitle A—National strategy for combating and
				eliminating tuberculosis</toc-entry>
					<toc-entry idref="H22FA78E8BB6A4639854052F13949F8EE" level="section">Sec. 101. National strategy.</toc-entry>
					<toc-entry idref="H0266F1D89689432481228C71179D004B" level="subtitle">Subtitle B—Interagency
				collaboration</toc-entry>
					<toc-entry idref="HC7F6865EC76C447DA900D96E65065700" level="section">Sec. 111. Advisory council for elimination of
				tuberculosis.</toc-entry>
					<toc-entry idref="H855320789197443681E3A972C4D626E2" level="subtitle">Subtitle C—New tools for tuberculosis
				elimination</toc-entry>
					<toc-entry idref="H3485E3CB46A842B098EF3CEAC1CD788" level="section">Sec. 121. New
				tools.</toc-entry>
					<toc-entry idref="H20A2471BF09344B6B35193CECC1FE620" level="subtitle">Subtitle D—Evaluation of public health
				authorities</toc-entry>
					<toc-entry idref="idBDC1DACFCCEE422B997A1426654F2A84" level="section">Sec. 131. Evaluation of public health
				authorities.</toc-entry>
					<toc-entry idref="id2D60AA45B81F43B6927A9C6B46D2D6B8" level="subtitle">Subtitle E—Authorization of
				appropriations</toc-entry>
					<toc-entry idref="HDA4BDE586B724F75B70059A41006B74" level="section">Sec. 141. Authorizations of
				appropriations.</toc-entry>
					<toc-entry idref="H211267994AD84E4388851C2F63ECD1F9" level="title">TITLE II—National Institutes of
				Health</toc-entry>
					<toc-entry idref="HF2BC1F9B5F434D39B61BEC61BC7E8E" level="section">Sec. 201. Research and development concerning
				tuberculosis.</toc-entry>
				</toc>
			</subsection></section><title changed="added" committee-id="SSHR00" id="id47136d38-3dd7-4d59-b5bf-ceb38e5e3ba0" reported-display-style="italic"><enum>I</enum><header>Department of health and
			 human services in coordination with the centers for disease control and
			 prevention and other appropriate agencies</header>
			<subtitle id="id5ad0e2ce-f365-4d16-90e7-cb7c1da2bab8"><enum>A</enum><header>National strategy for
			 combating and eliminating tuberculosis</header>
				<section id="id591b53d0-b488-4126-a7f3-c1153d747b33"><enum>101.</enum><header>National
			 strategy</header><text display-inline="no-display-inline">Section 317E of the
			 Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/247b-6">42 U.S.C. 247b–6</external-xref>) is
			 amended—</text>
					<paragraph id="id79abda5f-1cb0-4726-bb2f-1e62e70983ba"><enum>(1)</enum><text display-inline="yes-display-inline">by striking the heading for the section and
			 inserting the following: <quote><header-in-text level="section" style="traditional">national strategy for combating and eliminating
			 tuberculosis</header-in-text></quote>;</text>
					</paragraph><paragraph id="ida89d3ed3-5035-46e4-b4b9-023b63ef405c"><enum>(2)</enum><text>by amending subsection
			 (b) to read as follows:</text>
						<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="idca764efd-ff68-4532-a296-ea2daee86a87" reported-display-style="italic" style="OLC">
							<subsection id="idc9ef42c6-76bf-4b68-8ae3-7c19d36dd461"><enum>(b)</enum><header>Research and
				development; demonstration projects; education and training</header><text display-inline="yes-display-inline">With respect to the prevention, treatment,
				control, and elimination of tuberculosis, the Secretary may, directly or
				through grants to public or nonprofit private entities, carry out the
				following:</text>
								<paragraph id="id05883c8b-c073-46ce-aa7b-06b99b2371b8"><enum>(1)</enum><text display-inline="yes-display-inline">Research, with priority given to research
				and development concerning latent tuberculosis infection, strains of
				tuberculosis resistant to drugs, and research concerning cases of tuberculosis
				that affect certain populations at risk for tuberculosis.</text>
								</paragraph><paragraph id="id53358ac8-7930-4e58-9abe-6fba07655471"><enum>(2)</enum><text>Demonstration projects
				for—</text>
									<subparagraph id="id58d054db-4f6e-4ddd-8d3c-bb77d4d51eb7"><enum>(A)</enum><text>the development of
				regional capabilities to prevent, control and eliminate tuberculosis and
				prevent multidrug resistant and extensively drug resistant strains of
				tuberculosis;</text>
									</subparagraph><subparagraph id="idfa361a0f-2f98-4ce7-abae-3efff77b927d"><enum>(B)</enum><text display-inline="yes-display-inline">the intensification of efforts to reduce
				health disparities in the incidence of tuberculosis;</text>
									</subparagraph><subparagraph id="id0c42b499-7ca8-438c-b217-6620380fa2ad"><enum>(C)</enum><text display-inline="yes-display-inline">the intensification of efforts to control
				tuberculosis along the United States-Mexico border and among United
				States-Mexico binational populations, including through expansion of the scope
				and number of programs that—</text>
										<clause id="idB0B5CC9B1BE849DB87973A8F7DA5675F"><enum>(i)</enum><text display-inline="yes-display-inline">detect and treat binational cases of
				tuberculosis; and</text>
										</clause><clause id="id1665601B55E3491B9DC41D38AE7F3E56"><enum>(ii)</enum><text display-inline="yes-display-inline">treat high-risk cases of tuberculosis
				referred from Mexican health departments;</text>
										</clause></subparagraph><subparagraph id="id265690f2-fe84-4717-9fc0-c572f2849c58"><enum>(D)</enum><text>the intensification of
				efforts to prevent, detect, and treat tuberculosis among foreign-born persons
				who are in the United States;</text>
									</subparagraph><subparagraph id="idcb304259-90b2-4cbd-8847-bd25b7bd6550"><enum>(E)</enum><text>the intensification of
				efforts to prevent, detect, and treat tuberculosis among populations and
				settings documented as having a high risk for tuberculosis; and</text>
									</subparagraph><subparagraph id="id06D7ED2EA08A42EBA05257D7515DD49B"><enum>(F)</enum><text>tuberculosis detection,
				control, and prevention.</text>
									</subparagraph></paragraph><paragraph id="idb32e6630-6e3b-4350-b49f-89c22882b0b9"><enum>(3)</enum><text>Public information and
				education activities.</text>
								</paragraph><paragraph id="id210d8d37-29ac-47e7-a36b-ac03b952ae78"><enum>(4)</enum><text>Education, training,
				clinical skills improvement activities, and workplace exposure prevention for
				health professionals, including allied health personnel and emergency response
				employees.</text>
								</paragraph><paragraph id="id8600b13f-a82e-4e2c-b351-e37f091b0f33"><enum>(5)</enum><text display-inline="yes-display-inline">Support of Centers to carry out activities
				under paragraphs (1) through (4).</text>
								</paragraph><paragraph id="id9dd1e332-d261-477c-8e40-37a215f8da86"><enum>(6)</enum><text display-inline="yes-display-inline">Collaboration with international
				organizations and foreign countries in carrying out such activities.</text>
								</paragraph><paragraph id="id0105a0cb-455c-45dc-a514-e8f063472d09"><enum>(7)</enum><text>Develop, enhance, and
				expand information technologies that support tuberculosis control including
				surveillance and database management systems with cross-jurisdictional
				capabilities, which shall conform to the standards and implementation
				specifications for such information technologies as recommended by the
				Secretary.</text>
								</paragraph></subsection><after-quoted-block>;
				and</after-quoted-block></quoted-block>
					</paragraph><paragraph id="id8212D83ACAE641A9AD77D0B04CA0CCE1"><enum>(3)</enum><text>in subsection (d), by
			 adding at the end the following:</text>
						<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="idCD9580BD539842CCBD9ABDEFE149C031" reported-display-style="italic" style="OLC">
							<paragraph id="idA570A15F2CEA4C40B49983AB0F2E09FD"><enum>(3)</enum><header>Determination of amount
				of nonfederal contributions</header>
								<subparagraph id="idF9D1F1075F9D4308A1AAB6F7C7069E80"><enum>(A)</enum><header>Priority</header><text>In
				awarding grants under subsection (a) or (b), the Secretary shall give highest
				priority to an applicant that provides assurances that the applicant will
				contribute non-Federal funds to carry out activities under this section, which
				may be provided directly or through donations from public or private entities
				and may be in cash or in kind, including equipment or services.</text>
								</subparagraph><subparagraph id="id4A45D6ECB8D2454B9A642B4374CDF156"><enum>(B)</enum><header>Federal amounts not to
				be included as contributions</header><text>Amounts provided by the Federal
				Government, or services assisted or subsidized to any significant extent by the
				Federal Government, may not be included in determining the amount of
				non-Federal contributions as described in subparagraph
				(A).</text>
								</subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
					</paragraph></section></subtitle><subtitle id="id84036de4-69cf-4c5d-aa2b-2ec2db5f33b2"><enum>B</enum><header>Interagency
			 collaboration</header>
				<section id="ida8a2c784-1495-4a29-95a0-8a433179de8c"><enum>111.</enum><header>Advisory council for
			 elimination of tuberculosis</header>
					<subsection id="id3ecb060f-ada2-4c47-9cc5-7a2d5314831f"><enum>(a)</enum><header>In
			 general</header><text display-inline="yes-display-inline">Section 317E(f) of
			 the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/247b-6">42 U.S.C. 247b–6(f)</external-xref>) is
			 amended—</text>
						<paragraph id="id268c516e-f9b6-47e0-9d5d-43672ac52eec"><enum>(1)</enum><text display-inline="yes-display-inline">by redesignating paragraph (5) as paragraph
			 (6); and</text>
						</paragraph><paragraph id="id982c0330-b5c9-4756-b91a-74d294c31315"><enum>(2)</enum><text>by striking paragraphs
			 (2) through (4), and inserting the following:</text>
							<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="idb0e9312c-9569-4002-9228-1db6a6fb0fa2" reported-display-style="italic" style="OLC">
								<paragraph id="ida854031b-7809-4aa0-acb7-b19b36728aaa"><enum>(2)</enum><header>Duties</header><text display-inline="yes-display-inline">The Council shall provide advice and
				recommendations regarding the elimination of tuberculosis to the Secretary. In
				addition, the Council shall, with respect to eliminating such disease, provide
				to the Secretary and other appropriate Federal officials advice on—</text>
									<subparagraph id="idfd9bfed8-07c9-428b-a013-531700112c14"><enum>(A)</enum><text>coordinating the
				activities of the Department of Health and Human Services and other Federal
				agencies that relate to the disease, including activities under subsection
				(b);</text>
									</subparagraph><subparagraph id="id518c8bd7-3db4-4e11-9859-c5533fd19ec8"><enum>(B)</enum><text>responding rapidly and
				effectively to emerging issues in tuberculosis; and</text>
									</subparagraph><subparagraph id="id93563921-acc2-4dbc-b212-733a048ba084"><enum>(C)</enum><text>efficiently utilizing the
				Federal resources involved.</text>
									</subparagraph></paragraph><paragraph id="idb9c9fb3b-ff94-4daf-8115-978c243be43b"><enum>(3)</enum><header>Comprehensive
				plan</header>
									<subparagraph id="idd6de77ea-6f82-419f-9787-a18fcbc31934"><enum>(A)</enum><header>In
				general</header><text>In carrying out paragraph (2), the Council shall make or
				update recommendations on the development, revision, and implementation of a
				comprehensive plan to eliminate tuberculosis in the United States.</text>
									</subparagraph><subparagraph id="id338fe522-f2dd-41f2-b8ae-e9cd9f63e694"><enum>(B)</enum><header>Consultation</header><text>In
				carrying out subparagraph (A), the Council may consult with appropriate public
				and private entities, which may, subject to the direction or discretion of the
				Secretary, include—</text>
										<clause id="idb1590054-4429-435e-b573-96005de3101c"><enum>(i)</enum><text>individuals who are
				scientists, physicians, laboratorians, and other health professionals, who are
				not officers or employees of the Federal Government and who represent the
				disciplines relevant to tuberculosis elimination;</text>
										</clause><clause commented="no" id="id7a1d9612-2129-4188-a78b-931a78bcff93"><enum>(ii)</enum><text>members of
				public-private partnerships or private entities established to address the
				elimination of tuberculosis;</text>
										</clause><clause id="id6f70fda8-8940-4177-b2d2-178093e39a69"><enum>(iii)</enum><text>members of national and
				international nongovernmental organizations whose purpose is to eliminate
				tuberculosis; and</text>
										</clause><clause id="ida46ab431-e944-4229-a92a-86cc2718e7c0"><enum>(iv)</enum><text>members from the general
				public who are knowledgeable with respect to tuberculosis elimination including
				individuals who have or have had tuberculosis.</text>
										</clause></subparagraph><subparagraph commented="no" id="id17b4f6c3-8fc6-4fb5-9067-9d6ba9a51e41"><enum>(C)</enum><header>Certain components of
				plan</header><text display-inline="yes-display-inline">In carrying out
				subparagraph (A), the Council shall, subject to the direction or discretion of
				the Secretary—</text>
										<clause commented="no" id="idec8ac7a5-ee22-41c0-8a9d-d6698f7da647"><enum>(i)</enum><text>consider recommendations
				for the involvement of the United States in continuing global and cross-border
				tuberculosis control activities in countries where a high incidence of
				tuberculosis directly affects the United States; and</text>
										</clause><clause commented="no" id="id3c33b1e4-cd44-4a70-ad55-e7ebfa996763"><enum>(ii)</enum><text>review the extent to
				which progress has been made toward eliminating tuberculosis.</text>
										</clause></subparagraph></paragraph><paragraph commented="no" id="id1d9e7257-1943-43b9-ab4e-c947f5b95525"><enum>(4)</enum><header>Biennial
				report</header>
									<subparagraph commented="no" id="id46312BDE2635426297C349A31BF7A66D"><enum>(A)</enum><header>In
				general</header><text>The Council shall submit a biennial report to the
				Secretary, as determined necessary by the Secretary, on the activities carried
				under this section, other than subsection (g). Each such report shall include
				the opinion of the Council on the extent to which its recommendations regarding
				the elimination of tuberculosis have been implemented, including with respect
				to—</text>
										<clause commented="no" id="id6c54383a-ab89-4261-aab1-6e82c87d2e42"><enum>(i)</enum><text>activities under
				subsection (b); and</text>
										</clause><clause commented="no" id="idecc8786e-f139-4032-a96b-5f3b15135729"><enum>(ii)</enum><text>the national plan
				referred to in paragraph (3).</text>
										</clause></subparagraph><subparagraph commented="no" id="id0F09DDD5883B447B8A527281081A6D75"><enum>(B)</enum><header>Public</header><text>The
				Secretary shall make a report submitted under subparagraph (A) public.</text>
									</subparagraph></paragraph><paragraph id="id1b95122b-1cc6-4a9c-8520-7e698955558e"><enum>(5)</enum><header>Composition</header><text>The
				Council shall be composed of—</text>
									<subparagraph id="id47b377a1-ca16-4a0c-b344-6a34904a579d"><enum>(A)</enum><text>ex officio
				representatives from the Centers for Disease Control and Prevention, the
				National Institutes of Health, the United States Agency for International
				Development, the Agency for Healthcare Research and Quality, the Health
				Resources and Services Administration, the United States-Mexico Border Health
				Commission, and other Federal departments and agencies that carry out
				significant activities related to tuberculosis;</text>
									</subparagraph><subparagraph id="id367b70b5-008e-4fa8-b95a-42b9fc81082e"><enum>(B)</enum><text>State and local
				tuberculosis control and public health officials;</text>
									</subparagraph><subparagraph id="id99e33d88-d112-4afc-90ac-caeef05e1e90"><enum>(C)</enum><text display-inline="yes-display-inline">individuals who are scientists, physicians,
				laboratorians, and other health professionals who represent disciplines
				relevant to tuberculosis elimination; and</text>
									</subparagraph><subparagraph id="id4fe94a0f-8c6a-4e28-9cd5-4b1dcd4bfaa7"><enum>(D)</enum><text>members of national and
				international nongovernmental organizations established to address the
				elimination of
				tuberculosis.</text>
									</subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
						</paragraph></subsection><subsection id="id9fb81a7b-e822-4bef-82f5-611484863117"><enum>(b)</enum><header>Rule of construction
			 regarding current membership</header><text>With respect to the advisory council
			 under section 317E(f) of the Public Health Service Act, the amendments made by
			 subsection (a) may not be construed as terminating the membership on such
			 council of any individual serving as such a member as of the day before the
			 date of the enactment of this Act.</text>
					</subsection></section></subtitle><subtitle id="idfa3216e3-889c-4fc2-b697-7ddccb91a3a3"><enum>C</enum><header>New tools for
			 tuberculosis elimination</header>
				<section id="id8ca57c6a-02dc-4321-b46e-f49688d0b672"><enum>121.</enum><header>New
			 tools</header><text display-inline="no-display-inline">Section 317E of the
			 Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/247b-6">42 U.S.C. 247b–6</external-xref>) is
			 amended—</text>
					<paragraph id="id9edf8091-0332-42f9-a32f-7d76a26c3e84"><enum>(1)</enum><text>by redesignating
			 subsection (g) as subsection (h); and</text>
					</paragraph><paragraph id="idd3bd9261-1fd8-4efb-a7ad-dd2c2cb3534a"><enum>(2)</enum><text>by inserting after
			 subsection (f) the following subsection:</text>
						<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="idf28793af-624f-45b0-a8ea-e21417029cff" reported-display-style="italic" style="OLC">
							<subsection id="id41f20ca9-7804-43b3-9e38-5ac710c5d541"><enum>(g)</enum><header>New tools for
				elimination of tuberculosis</header>
								<paragraph id="id080ee0f0-8822-4df2-9ce3-d4bc114e058d"><enum>(1)</enum><header>Research and
				development on drugs, diagnostics, vaccines, and public health
				interventions</header><text>The Secretary may expand, intensify, and coordinate
				research and development and related activities to develop new tools for the
				elimination of tuberculosis, including drugs, diagnostics, vaccines, and public
				health interventions, such as directly observed therapy and non-pharmaceutical
				intervention, and methods to enhance detection and response to outbreaks of
				tuberculosis, including multidrug resistant tuberculosis. The Secretary shall
				give priority to programmatically relevant research so that new tools can be
				utilized in public health practice.</text>
								</paragraph><paragraph id="id96f67def-bf39-4d9d-9192-8bc957178a36"><enum>(2)</enum><header>Federal tuberculosis
				task force</header>
									<subparagraph id="id25ba9b8c-248b-478d-8013-1507e634addd"><enum>(A)</enum><header>Duties</header><text>The
				Federal Tuberculosis Task Force (in this subsection referred to as the
				<quote>Task Force</quote>) shall provide to the Secretary and other appropriate
				Federal officials advice on the implementation of paragraph (1), including
				advice regarding the efficient utilization of the Federal resources
				involved.</text>
									</subparagraph><subparagraph id="ide5cddc64-9589-4064-9a0c-8c07ab3310b9"><enum>(B)</enum><header>Comprehensive plan for
				new tools development</header><text>In carrying out paragraph (1), the Task
				Force shall make recommendations on the development of a comprehensive plan for
				the creation of new tools for the elimination of tuberculosis, including drugs,
				diagnostics, and vaccines.</text>
									</subparagraph><subparagraph id="id84521df5-6e55-40d2-9e99-d543f8ff3889"><enum>(C)</enum><header>Consultation</header><text>In
				developing the comprehensive plan under paragraph (1), the Task Force shall
				consult with external parties including representatives from groups such
				as—</text>
										<clause id="id0df5d827-4315-44e0-9f15-ac44caf3238c"><enum>(i)</enum><text>scientists, physicians,
				laboratorians, and other health professionals who represent the specialties and
				disciplines relevant to the research under consideration;</text>
										</clause><clause id="idcd12cb0e-ec2e-43c9-a7bc-ce5e761cb5c2"><enum>(ii)</enum><text display-inline="yes-display-inline">members from public-private partnerships,
				private entities, or foundations (or both) engaged in activities relevant to
				research under consideration;</text>
										</clause><clause id="id91ad5b6b-72d8-4eea-8357-f081f248e544"><enum>(iii)</enum><text>members of national and
				international nongovernmental organizations established to address tuberculosis
				elimination;</text>
										</clause><clause id="idb17f4ee6-b479-4450-9c01-a2bd9aa555cb"><enum>(iv)</enum><text>members from the general
				public who are knowledgeable with respect to tuberculosis including individuals
				who have or have had tuberculosis; and</text>
										</clause><clause id="id38e34be9-2140-41ec-8c1d-23a77759fd8f"><enum>(v)</enum><text>scientists, physicians,
				laboratorians, and other health professionals who reside in a foreign country
				with a substantial incidence or prevalence of tuberculosis, and who represent
				the specialties and disciplines relevant to the research under
				consideration.</text>
										</clause></subparagraph></paragraph><paragraph id="id3af30ea4-be18-41ff-993d-aaa7b8242939"><enum>(3)</enum><header>Grants and
				contracts</header><text>The Secretary may carry out paragraph (1) directly and
				through awards of grants, cooperative agreements, and contracts to public and
				private entities, including—</text>
									<subparagraph id="idb6d61d06-672c-4018-a759-c89651739c00"><enum>(A)</enum><text>public-private
				partnerships;</text>
									</subparagraph><subparagraph id="idfbf8c469-bbb1-4b12-ae83-a0d1ae87b399"><enum>(B)</enum><text>academic institutions,
				including institutions of higher education;</text>
									</subparagraph><subparagraph id="idb18ed626-0f72-4f8f-937e-2c60f9d18a87"><enum>(C)</enum><text>research institutions;
				and</text>
									</subparagraph><subparagraph id="IDc10c0f045eb54653974556bd04e9bd61"><enum>(D)</enum><text>nonprofit entities
				established and dedicated to tuberculosis vaccine and treatment product
				development.</text>
									</subparagraph></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
					</paragraph></section></subtitle><subtitle id="iddc8a545f-1218-4b83-8c78-9709e143d32b"><enum>D</enum><header>Evaluation of public
			 health authorities</header>
				<section id="idBDC1DACFCCEE422B997A1426654F2A84"><enum>131.</enum><header>Evaluation of public
			 health authorities</header>
					<subsection id="idF0611AEA547C48D88E9DE955FC3BB71B"><enum>(a)</enum><header>In
			 general</header><text>Not later than 180 days after the date of enactment of
			 the Comprehensive Tuberculosis Elimination Act of 2007, the Secretary of Health
			 and Human Services shall prepare and submit to the appropriate committees of
			 Congress a report that evaluates and provides recommendations on changes needed
			 to Federal and State public health authorities to address current disease
			 containment challenges such as isolation and quarantine.</text>
					</subsection><subsection id="idF64074C29AFB48518F024465C248EFCB"><enum>(b)</enum><header>Contents of
			 evaluation</header><text>The report described in subsection (a) shall
			 include—</text>
						<paragraph id="IDa00c4ca1a2da44b1a92d4ac549f952cf"><enum>(1)</enum><text>an evaluation of the
			 effectiveness of current policies to detain patients with active
			 tuberculosis;</text>
						</paragraph><paragraph id="ID6472d1ae78c5470a8b4776345f06b9aa"><enum>(2)</enum><text>an evaluation of whether
			 Federal laws should be strengthened to expressly address the movement of
			 individuals with active tuberculosis; and</text>
						</paragraph><paragraph id="ID28e2a6ec7e864914bd7839d7b04b2cd1"><enum>(3)</enum><text>specific legislative
			 recommendations for changes to Federal laws, if any.</text>
						</paragraph></subsection><subsection id="id3D89D053F14E413295B1C42D5DB0C523"><enum><added-phrase reported-display-style="italic">(c)</added-phrase></enum><header>Update of
			 quarantine regulations</header><text>Not later than 240 days after the date of
			 enactment of this Act, the Secretary of Health and Human Services shall
			 promulgate regulations to update the current interstate and foreign quarantine
			 regulations found in parts 70 and 71 of title 42, Code of Federal
			 Regulations.</text>
					</subsection></section></subtitle><subtitle id="id2D60AA45B81F43B6927A9C6B46D2D6B8"><enum>E</enum><header>Authorization of
			 appropriations</header>
				<section id="idddbf66e0-2007-48be-b993-b5bc46276bd6"><enum>141.</enum><header>Authorizations of
			 appropriations</header><text display-inline="no-display-inline">Section 317E of
			 the Public Health Service Act, as amended by section 121(1) of this Act, is
			 amended by striking subsection (h) and inserting the following:</text>
					<quoted-block changed="added" committee-id="SSHR00" display-inline="no-display-inline" id="id85f646a6-8c5c-496b-a3a5-be94b00c25b5" reported-display-style="italic" style="OLC">
						<subsection id="idbfc0a081-dc29-4c14-bd99-c49193fce9c7"><enum>(h)</enum><header>Authorization of
				appropriations</header>
							<paragraph id="id30362ef9-bfee-4633-b23a-e1f5af910dc6"><enum>(1)</enum><header>General
				program</header>
								<subparagraph id="idaa7d2610-6169-470e-b768-6f7763b83422"><enum>(A)</enum><header>In
				general</header><text>For the purpose of carrying out this section, other than
				subsections (b) and (g), there are authorized to be appropriated $300,000,000
				for fiscal year 2008, and such sums as may be necessary for each of the fiscal
				years 2009 through 2012.</text>
								</subparagraph><subparagraph id="id16f50572-6041-477b-b45b-bb8185046e96"><enum>(B)</enum><header>Reservation for
				emergency grants</header><text>Of the amounts appropriated under subparagraph
				(A) for a fiscal year, the Secretary may reserve not more than 25 percent for
				emergency grants under subsection (a) for any geographic area, State, political
				subdivision of a State, or other public entity in which there is, relative to
				other areas, a substantial number of cases of tuberculosis, multidrug resistant
				tuberculosis, or extensively drug resistant tuberculosis or a substantial rate
				of increase in such cases.</text>
								</subparagraph><subparagraph id="id146bc490-5f3c-4b3f-a5b1-cd6bbb0af1af"><enum>(C)</enum><header>Research, demonstration
				projects, education, and training</header><text>For the purpose of carrying out
				subsection (b), there are authorized to be appropriated such sums as may be
				necessary for each of fiscal years 2008 through 2012.</text>
								</subparagraph><subparagraph id="id6ac18c87-d654-4738-96bf-b68a287aae0c"><enum>(D)</enum><header>Priority</header><text display-inline="yes-display-inline">In allocating amounts appropriated under
				subparagraph (A) and not reserved under subparagraph (B), the Secretary shall
				give priority to allocating such amounts for grants under subsection
				(a).</text>
								</subparagraph><subparagraph id="id785dfd61-b4a2-4e5d-8c32-188bb7befa9d"><enum>(E)</enum><header>Allocation of
				funds</header>
									<clause id="id274a3df8-f03d-4029-9b3e-18e246dcbc25"><enum>(i)</enum><header>Requirement of
				formula</header><text>Of the amounts appropriated under subparagraph (A), not
				reserved under subparagraph (B), and allocated by the Secretary for grants
				under subsection (a), the Secretary shall distribute a portion of such amounts
				to grantees under subsection (a) on the basis of a formula.</text>
									</clause><clause id="idb2f3b442-7442-4b6c-af88-cdeb0fb49b98"><enum>(ii)</enum><header>Relevant
				factors</header><text>The formula developed by the Secretary under clause (i)
				shall take into account the level of tuberculosis morbidity and case complexity
				in the respective geographic area and may consider other factors relevant to
				tuberculosis in such area.</text>
									</clause><clause id="id491b915e-8131-418c-a71c-9c1ebcfbc4e2"><enum>(iii)</enum><header>No change to formula
				required</header><text>This subparagraph does not require the Secretary to
				modify the formula that was used by the Secretary to distribute funds to
				grantees under subsection (a) for fiscal year 2007.</text>
									</clause></subparagraph></paragraph><paragraph id="id724e0390-05b5-4118-b40b-2dfa68b92325"><enum>(2)</enum><header>New tools</header>
								<subparagraph id="id86850176-a842-428c-b310-89626507e670"><enum>(A)</enum><header>In
				general</header><text>For the purpose of carrying out subsection (g), there are
				authorized to be appropriated $100,000,000 for fiscal year 2008, and such sums
				as may be necessary for each of the fiscal years 2009 through 2012.</text>
								</subparagraph><subparagraph id="id3980e8fa-06f4-4d2c-860f-7db8fe0ca241"><enum>(B)</enum><header>Limitation</header><text>The
				authorization of appropriations established in subparagraph (A) for a fiscal
				year is effective only if the amount appropriated under paragraph (1) for such
				year equals or exceeds the amount appropriated to carry out this section for
				fiscal year
				2007.</text>
								</subparagraph></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
				</section></subtitle></title><title changed="added" committee-id="SSHR00" id="id91501201-528e-4261-8d8c-b4e91203615c" reported-display-style="italic"><enum>II</enum><header>National Institutes of
			 Health</header>
			<section id="idd46cb755-942b-4b08-9ac7-0b23b258f966"><enum>201.</enum><header>Research and
			 development concerning tuberculosis</header><text display-inline="no-display-inline">Subpart 2 of part C of title IV of the
			 <act-name parsable-cite="PHSA">Public Health Service Act</act-name> (42 U.S.C.
			 285b et seq.) is amended by inserting after section 424B the following
			 section:</text>
				<quoted-block act-name="Public" changed="added" committee-id="SSHR00" id="idfc2a4474-9f8a-4679-8e2b-1e52783fa5b9" reported-display-style="italic" style="OLC">
					<section id="ida94861cf-740a-46d5-a14f-d7ec6330d005"><enum>424C.</enum><header>Tuberculosis</header>
						<subsection display-inline="no-display-inline" id="idf1618c13-7643-4ad6-bc6c-8e652b014c0a"><enum>(a)</enum><header>In
				General</header><text>The Director of the National Institutes of Health may
				expand, intensify, and coordinate research and development and related
				activities of the Institute with respect to tuberculosis including activities
				toward the goal of eliminating such disease.</text>
						</subsection><subsection id="ida4fb92bc-f4f6-40c0-b867-e7436d8e1d7c"><enum>(b)</enum><header>Certain
				Activities</header><text>Activities under subsection (a) may include—</text>
							<paragraph id="id68733f6d-ad41-4e0d-89bc-ed74ec1ba401"><enum>(1)</enum><text>enhancing basic and
				clinical research on tuberculosis, including drug resistant tuberculosis;
				and</text>
							</paragraph><paragraph id="ida07ee074-0fa6-4ec7-aba1-1fe5334f8ff7"><enum>(2)</enum><text>expanding research on the
				relationship between such disease and the human immunodeficiency
				virus.</text>
							</paragraph></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block>
			</section></title></legis-body>
	<endorsement>
		<action-date>December 18, 2007</action-date>
		<action-desc>Reported with an amendment</action-desc>
	</endorsement>
</bill>
